J. Soto

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Anirvan Ghosh, A. Monsch, R. Postuma, 2018, Movement disorders : official journal of the Movement Disorder Society.

First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers

M. Grundman, D. Schenk, W. Zago, 2016, Movement disorders : official journal of the Movement Disorder Society.

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–&agr;-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial

J. Jankovic, J. Quinn, M. Grundman, 2018, JAMA neurology.

Large-Scale Continuous Mobility Monitoring of Parkinson's Disease Patients Using Smartphones

Liping Jin, Detlef Wolf, Martin Koller, 2017, MobiHealth.

Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease

J. Jankovic, D. Jennings, J. Quinn, 2018 .

Smartphone-based continuous mobility monitoring of Parkinsons disease patients reveals impacts of ambulatory bout length on gait features

Martin Koller, Anirvan Ghosh, Wei-Yi Cheng, 2017, 2017 IEEE Life Sciences Conference (LSC).

Human Activity Recognition from Sensor-Based Large-Scale Continuous Monitoring of Parkinson’s Disease Patients

Liping Jin, Detlef Wolf, Martin Koller, 2017, 2017 IEEE/ACM International Conference on Connected Health: Applications, Systems and Engineering Technologies (CHASE).